Trials / Completed
CompletedNCT02805166
PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy
The Multi-center,Open-label,Single Arm Phase IV Clinical Trial of Efficacy and Safety of PEG-rhG-CSF in Patients With Lung Cancer,Head and Neck Cancer,Colorectal Cancer,Ovarian Cancer and the Other Cancer Receiving Chemotherapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 420 (actual)
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the safety and efficacy of PEG-rhG-CSF in patients with lung cancer,head and neck cancer,colorectal cancer,and ovarian cancer receiving multi-cycle chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-rhG-CSF |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2016-06-17
- Last updated
- 2016-06-17
Source: ClinicalTrials.gov record NCT02805166. Inclusion in this directory is not an endorsement.